Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-40
Closed -$8.79K 716
2023
Q4
$8.79K Hold
40
﹤0.01% 594
2023
Q3
$8.78K Hold
40
﹤0.01% 594
2023
Q2
$9K Hold
40
﹤0.01% 605
2023
Q1
$7.65K Hold
40
﹤0.01% 649
2022
Q4
$7K Sell
40
-13
-25% -$2.29K ﹤0.01% 673
2022
Q3
$9K Hold
53
﹤0.01% 665
2022
Q2
$11K Hold
53
﹤0.01% 680
2022
Q1
$13K Buy
+53
New +$12.3K ﹤0.01% 724

Other funds holding STE

Cambridge Trust's STE Position: Q1 2024 in Review

Cambridge Trust sold out of Steris (STE) in Q1 2024, closing a stake of 40 shares — an estimated $8.79K sold.

Cambridge Trust first reported a position in STE in Q1 2022 and held it in 8 quarters. The position peaked at $13K in Q1 2022. 727 funds tracked by Wall St. Rank hold STE as of Q1 2024.

  • Cambridge Trust reported no remaining Steris position as of Q1 2024 after selling out during the quarter.
  • Cambridge Trust sold 40 Steris shares in Q1 2024, an estimated $8.79K.
  • Cambridge Trust first reported a position in Steris in Q1 2022 and held it in 8 quarters.
  • Cambridge Trust's Steris position peaked at $13K in Q1 2022.
  • 727 funds tracked by Wall St. Rank held Steris as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.